BRUIN CLL-322 is the first Phase 3 study to demonstrate superiority over a venetoclax-containing control arm in CLL, and, with the majority of patients...
CAPE TOWN, South Africa, June 13, 2026 /PRNewswire/ -- This is exactly why Junkies Coder an Africa-based software engineering company has launched its Agentic AI...
DUBAI, UAE, June 13, 2026 /PRNewswire/ -- This is why Junkies Coder UAE-based Company has launched its Agentic AI & Enterprise Modernisation practice —...
HYDERABAD, India, June 13, 2026 /PRNewswire/ -- QNET has taken note of recent media reports published in Telangana concerning the alleged activities of an...
NEWTOWN, Pa., June 12, 2026 (GLOBE NEWSWIRE) -- Traws Pharma, Inc. (NASDAQ: TRAW, the Company), a clinical-stage biopharmaceutical company developing novel therapies for critical global viral threats, today announced that the planned test of tivoxavir marboxil (TXM) in a Phase 2a human influenza challenge study has been deferred due to a negative review of the program by the United Kingdom’s Medicines and Healthcare Products Regulatory Agency (MHRA).
New senior moving certification program helps older adults move with greater confidence and supportINDIANAPOLIS, June 11, 2026 /PRNewswire/ -- Bekins Van Lines announces the...
HONG KONG, June 11, 2026 /PRNewswire/ -- Akeso, Inc. (9926.HK) today announced that the National Medical Products Administration (NMPA) of China has approved gumokimab...
Limited-Time 618 Promotion Offers Savings on Selected Health and Wellness ProductsHONG KONG, June 12, 2026 /PRNewswire/ -- As summer approaches, the enthusiasm for running,...
Rename and redomestication to Texas unify the Company’s multi-model platform under the identity and governance framework that has always defined it: the agent
Rename and redomestication to Texas unify the Company’s multi-model platform under the identity and governance framework that has always defined it: the agent